New diabetes drug shows promise in Mid-Stage trial
NCT ID NCT01022112
First seen Jan 11, 2026 · Last updated Apr 29, 2026 · Updated 15 times
Summary
This study tested an experimental pill called TA-7284 in 383 adults with type 2 diabetes. The goal was to see if it safely lowers blood sugar and helps with weight. Participants took either the drug or a placebo for several weeks. The results will help decide if larger studies are needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research site
Chugoku, Japan
-
Research site
Kanto, Japan
-
Research site
Kinki, Japan
-
Research site
Kyushu, Japan
-
Research site
Shikoku, Japan
-
Research site
Tōhoku, Japan
Conditions
Explore the condition pages connected to this study.